Jubilant Pharmova Ltd. (JUBILANT LIFE SCIENCES )

Company Overview

Jubilant Pharmova Ltd. is a pharmaceutical company offering radiopharmaceuticals, allergy immunotherapies, generics, and branded drugs. It also offers contract research development and manufacturing (CRDMO) services. The company’s Radiopharma business consists of two divisions: Radiopharmaceuticals and Radiopharmacies. Radiopharmaceutical business develops and manufactures radiopharmaceuticals. Radiopharmacies operates a network of 46 nuclear pharmacies (43 SPECT and 3 PET) in the U.S. Jubilant Pharmova’ current focus is to expand PET nuclear pharmacies network in the U.S.

The Allergy Immunotherapy business manufactures and markets allergic extracts and venom products in the U.S., Canada, Europe, and Australia. The CDMO Sterile Injectables business offers manufacturing services, including sterile fill and finish injectables, full-service ophthalmic offers and ampoules.

Financial Highlights (FY 2024)

Company's Business Segments

• Radiopharma : This segment includes the development, manufacturing, and commercialization of developing, manufacturing, and commercializing of products through the
• Allergy Immunotherapy : Radiopharmaceuticals business and distributions.
• Contract Development and Manufacturing Organisation (CDMO) Sterile Injectables : This segment offers preventive treatments for allergic reactions to a variety of allergens, including Pollen, Mold, PET dander, Food, and Insects (treated by venom immunotherapy).
• Generics : This segment is primarily driven by the increase in the development pipeline in biologics and the loss of exclusivity.
• Contract Research, Development and Manufacturing Organisation (CRDMO) : This business includes developing, manufacturing, distributing, selling, and marketing generic formulations.